Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Changzhou SPL Company, Ltd ( a/k/a "Kaipu")
WARNING LETTER
•Changzhou SPL Company, Ltd ( a/k/a "Kaipu")•February 26, 2008

Changzhou SPL Company, Ltd ( a/k/a "Kaipu") – FDA Warning Letter, Feb 26, 2008

Record Details

This FDA Warning Letter, dated April 21, 2008, was issued to Changzhou SPL Company, Ltd (aka "Kaipu") following an inspection from February 20-26, 2008. The inspection revealed significant deviations from U.S. Current Good Manufacturing Practice (CGMP) in the manufacture of active pharmaceutical ingredients (API), specifically heparin sodium, USP, rendering their API adulterated under section 501(a)(2)(B) of the Federal Food, Drug, and Cosmetic Act.

Key violations include: 1. **Lack of assurance for impurity removal:** The firm lacked adequate evaluation of critical processing steps for impurity removal, and critical process parameters were not well-defined or controlled. An impurity profile for heparin sodium API was not established, and validation studies failed to demonstrate consistent impurity removal. 2. **Inadequate supplier evaluation:** The firm failed to have adequate systems for evaluating suppliers of heparin crude materials, using material from an "unacceptable" vendor in API shipped to the U.S. 3. **Unverified test methods:** USP compendial test methods for heparin sodium USP were not verified for suitability under actual conditions of use, particularly the protein test method, lacking data on suitability, accuracy, and detection limits. 4. **Unsuitable equipment:** Equipment tanks used in the final processing step were observed with adhering unidentified material, scratches, and non-smooth surfaces, indicating

Company
Changzhou SPL Company, Ltd ( a/k/a "Kaipu")
Inspection date
February 26, 2008
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Richard L. Friedman (Director)
View Company Profile

ID · 9b58e9b0-ff10-4143-9249-98a936d3caa2

Violation Codes3
21 U.S.C. 381(a)(3)FD&C Act 801(a)(3)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Changzhou SPL Company, Ltd ( a/k/a "Kaipu")
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.